Anupam Rasayan India reported a 12% increase in net profit to Rs 61 crore for Q3 FY26, driven by a 31.35% rise in total revenue to Rs 512.44 crore. The company also announced a significant strategic development with the agreement to acquire US-based Jayhawk Fine Chemicals Corporation, strengthening its global presence and custom synthesis capabilities.
Dr Reddy’s shares slide 7% after delay in semaglutide supplies over quality concerns
Dr Reddy’s shares fell sharply on Thursday after the company delayed commercial supplies of its semaglutide product due to a quality issue involving the active